Year | Distinct count of drug name | Items | Items per 1000 | Cost | Inflation- corrected cost | Inflation- corrected cost per 1000 | ||
n | n | n | Change (%) | £ | 2016 £ | 2016 £ | Change (%) | |
1998 | 6338 | 497.0 million | 10 180 | £4440 million | £6280 million | £128 626 | ||
1999 | 6587 | 513.4 million | 10 471 | +2.9 | £5011 million | £6999 million | £142 746 | +11.0 |
2000 | 6613 | 535.1 million | 10 868 | +3.8 | £5284 million | £7318 million | £148 648 | +4.1 |
2001 | 6754 | 569.2 million | 11 510 | +5.9 | £5784 million | £7914 million | £160 049 | +7.7 |
2002 | 6834 | 598.6 million | 12 050 | +4.7 | £6487 million | £8768 million | £176 491 | +10.3 |
2003 | 6893 | 630.3 million | 12 625 | +4.8 | £7113 million | £9488 million | £190 035 | +7.7 |
2004 | 6912 | 666.0 million | 13 268 | +5.1 | £7645 million | £10 063 million | £200 482 | +5.5 |
2005 | 6907 | 698.8 million | 13 808 | +4.1 | £7452 million | £9609 million | £189 875 | −5.3 |
2006 | 6810 | 728.4 million | 14 292 | +3.5 | £7660 million | £9655 million | £189 436 | −0.2 |
2007 | 7056 | 771.8 million | 15 022 | +5.1 | £7810 million | £9614 million | £187 112 | −1.2 |
2008 | 7202 | 816.7 million | 15 762 | +4.9 | £7716 million | £9174 million | £177 047 | −5.4 |
2009 | 7401 | 859.2 million | 16 461 | +4.4 | £7892 million | £9176 million | £175 805 | −0.7 |
2010 | 11 703 | 898.4 million | 17 065 | +3.7 | £8162 million | £9193 million | £174 636 | −0.7 |
2011 | 11 751 | 931.6 million | 17 541 | +2.8 | £8101 million | £8734 million | £164 457 | −5.8 |
2012 | 12 207 | 968.9 million | 18 112 | +3.3 | £7802 million | £8176 million | £152 836 | −7.1 |
2013 | 12 318 | 996.2 million | 18 494 | +2.1 | £7846 million | £8022 million | £148 920 | −2.6 |
2014 | 12 576 | 1027.0 million | 18 908 | +2.2 | £8022 million | £8078 million | £148 718 | −0.1 |
2015 | 12 875 | 1043.5 million | 19 046 | +0.7 | £8403 million | £8461 million | £154 444 | +3.9 |
2016 | 13 285 | 1060.9 million | 19 196 | +0.8 | £8284 million | £8284 million | £149 892 | −2.9 |
Total | 22 496 | 14 810.9 million | 2 84 680 | +3.6 | £1 36 914 million | £1 63 006 million | £3 160 254 | +1.0 |
‘Drug name’ is the field describing the presentation of each drug, that is, its formulation, dose and product name. Costs represent net ingredient cost (see box 1). ‘Change’ is the year-on-year change.
PCA, prescription cost analysis.